South and Central America Embolization Agents Market Share and Forecast by 2028
South and Central America Embolization Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Coils, Plugs, Beads/ Particles, Detachable Balloons, Glue, Sponge, Liquid Embolics, Sclerosants, Precipitating Agents, and Others), Application (Oncology, Neurology, Urology, Cardiology, Peripheral Vascular Diseases, and Others), and End User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers, and Others)
- Report Date : Nov 2021
- Report Code : TIPRE00026131
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 150
The embolization agents market in South and Central America is expected to grow from US$ 167.17 million in 2021 to US$ 262.40 million by 2028; it is estimated to grow at a CAGR of 6.7% from 2021 to 2028.
Embolization agents are used to acutely stop the flow in a blood vessel or vascular territory by the means of mechanical occlusion. Embolization is a common procedure in interventional radiology. Embolizing agents like embolic microspheres (beads) are used to restrict the vascular supply of tumors and can be loaded with chemotherapeutic medicines, which elute and diffuse into the tissue. Liquid embolic agents are used to prevent blood supply to aneurysm or tumor. It helps in the prevention of aneurysms and tumors from growing and causing harm to essential organ. Thus, increasing prevalence of aneurysms and cancers is creating high demand for South and Central America embolization agents marketThe increasing number of COVID-19 cases in Brazil, Peru, Chile, Ecuador, and Venezuela is likely to have negative impact on the South and Central America embolization agents market. For instance, in Brazil, the number of cases has reached ~18,513,305, with 516,119 deaths, as per the world meter data of June 2021. With the onset of the second wave of COVID-19 pandemic, there has been an increasing number of cases in the South American countries. According to the International Council of Nurses, the number of deaths of health professionals in Brazil are greater than the numbers in other countries, which can be associated with the high transmission of the virus. As Brazil has many populated regions with small houses with 6-7 people per house, the virus has spread rapidly. Currently, the countries in this region are rapidly increasing its clinical programs to fight against the novel coronavirus. In this scenario, Brazil is facing enormous difficulties in the management of cancer, head and neck surgeries, chronic neurological disorders such as brain aneurysms, and headache and neurodegenerative diseases. Due to inadequate monitoring, many patients end up being admitted to emergency departments due to decompensation of their cancer and neurological disease. During the pandemic, patients with cancer and stroke, as well as other neurological conditions, have been arriving late at the hospital, and the treatment procedures of such patients fall outside the therapeutic window for acute intervention. In addition, the country also faced difficulties in obtaining beds in the intensive care unit for management of these disease amid the COVID-19 crisis. These factors are limiting the South and Central America embolization agents market growth.
South and Central America Embolization Agents Market Revenue and Forecast to 2028 (US$ Million)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
South and Central America Embolization Agents Market Segmentation
South and Central America Embolization Agents Market – By Product
- Coils
- Detachable Coils
- Pushable Coils
- Beads/ Particles
- Spherical
- Non-Spherical
- Plugs
- Detachable Balloons
- Glue
- Sponge
- Liquid Embolics
- Sclerosants
- Precipitating Agents
- Others
South and Central America Embolization Agents Market – By Application
- Oncology
- Neurology
- Urology
- Cardiology
- Peripheral Vascular Diseases
- Others
South and Central America Embolization Agents Market – By End User
- Hospitals
- Cardiac Centers
- Ambulatory Surgical Centers
- Others
South and Central America Embolization Agents Market– By Country
- Brazil
- Argentina
- Rest of South and Central America
South and Central America Embolization Agents Market-Companies Mentioned
- Abbott
- Boston Scientific Corporation
- Cook Medical LLC
- DePuy Synthes
- KANEKA CORPORATION
- Medtronic
- Merit Medical Systems Inc
- Stryker Corporation
- Terumo Corporation
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 SCAM Embolization Agents Market – By Product
1.3.2 SCAM Embolization Agents Market – By Application
1.3.3 SCAM Embolization Agents Market – By End User
1.3.4 SCAM Embolization Agents Market – By Country
2. SCAM Embolization Agents Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SCAM Embolization Agents Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South and Central America (SCAM) – PEST Analysis
4.3 Experts Opinion
5. SCAM Embolization Agents Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in the Incidence of Tumors and Aneurysms
5.1.1 Growing Incidence of Hypertension, Obesity, Smoking, and Alcoholism
5.2 Market Restraints
5.2.1 High Cost of Embolization Agents
5.3 Market Opportunities
5.3.1 Growing Geriatric Population Base
5.4 Future Trends
5.4.1 Technological Advancements in Embolization Products and Procedures
5.5 Impact analysis
6. Embolization Agents Market – SCAM Analysis
6.1 SCAM Embolization Agents Market Revenue Forecast and Analysis
7. SCAM Embolization Agents Market Analysis – By Product
7.1 Overview
7.2 SCAM Embolization Agents Market Revenue Share, by Products (2021 and 2028)
7.3 Coils
7.3.1 Overview
7.3.2 Coils: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Detachable Coils
7.3.2.1.1 Detachable Coil Market Revenue and Forecast to 2028 (US$ Mn)
7.3.2.1.2 Detachable Coil Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.2 Pushable Coils
7.3.2.2.1 Pushable Coil Market Revenue and Forecast to 2028 (US$ Mn)
7.3.2.2.2 Pushable Coil Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Beads/Particles
7.4.1 Overview
7.4.2 Beads/Particles: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.4.2.1 Spherical
7.4.2.1.1 Spherical Market Revenue and Forecast to 2028 (US$ Mn)
7.4.2.1.2 Spherical Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.2.2 Non-Spherical
7.4.2.2.1 Non-Spherical Market Revenue and Forecast to 2028 (US$ Mn)
7.4.2.2.2 Non-Spherical Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Plugs
7.5.1 Overview
7.5.2 Plugs: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.6 Detachable Balloons
7.6.1 Overview
7.6.2 Detachable Balloons: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.7 Glue
7.7.1 Overview
7.7.2 Glue: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.8 Sponge
7.8.1 Overview
7.8.2 Sponge: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.9 Liquid Embolics
7.9.1 Overview
7.9.2 Liquid Embolics: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.10 Sclerosants
7.10.1 Overview
7.10.2 Sclerosants: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.11 Precipitating Agents
7.11.1 Overview
7.11.2 Precipitating Agents: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.12 Others
7.12.1 Overview
7.12.2 Others: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
8. SCAM Embolization Agents Market Analysis – By Application
8.1 Overview
8.2 SCAM Embolization Agents Market, by Application 2021 & 2028 (%)
8.3 Oncology
8.3.1 Overview
8.3.2 Oncology: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Neurology
8.4.1 Overview
8.4.2 Neurology: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Urology
8.5.1 Overview
8.5.2 Urology: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Cardiology
8.6.1 Overview
8.6.2 Cardiology: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Peripheral Vascular Diseases
8.7.1 Overview
8.7.2 Peripheral Vascular Diseases: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9. SCAM Embolization Agents Market Analysis – By End User
9.1 Overview
9.2 SCAM Embolization Agents Market Revenue Share, By End User (2021 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Cardiac Centers
9.4.1 Overview
9.4.2 Cardiac Centers: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
10. SCAM Embolization Agents Market – Country Analysis
10.1 South and Central America: Embolization Agents Market
10.1.1 Overview
10.1.2 South and Central America Embolization Agents Market, by Country, 2021 & 2028 (%)
10.1.2.1 Brazil: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Brazil: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.2 Brazil: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.2.1 Brazil: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2.2 Brazil: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3 Brazil: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.4 Brazil: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2 Argentina: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Argentina: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.2 Argentina: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.2.1 Argentina: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2.2 Argentina: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3 Argentina: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.4 Argentina: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3 Rest of South and Central America: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Rest of South and Central America: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.2 Rest of South and Central America: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.2.1 Rest of South and Central America: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 Rest of South and Central America: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.4 Rest of South and Central America: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.5 Rest of South and Central America: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on SCAM Embolization Agents Market
11.1 South & Central America: Impact Assessment of COVID-19 Pandemic
12. SCAM Embolization Agents Market–Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Medtronic
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Terumo Corporation
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Cook Medical LLC
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Boston Scientific Corporation
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Abbott
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Stryker Corporation
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Merit Medical Systems Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 DePuy Synthes
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 KANEKA CORPORATION
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ million)
Table 2. Brazil: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 3. Brazil: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
Table 4. Brazil: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 5. Brazil: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 6. Brazil: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. Argentina: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 8. Argentina: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
Table 9. Argentina: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 10. Argentina: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 11. Argentina: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 12. Rest of South and Central America: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 13. Rest of South and Central America: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (US$ Million)
Table 14. Rest of South and Central America: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 15. Rest of South and Central America: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of South and Central America: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Organic Developments Done by Companies
Table 18. Inorganic Developments Done by Companies
Table 19. Glossary of Terms, SCAM Embolization Agents Market
LIST OF FIGURES
Figure 1. SCAM Embolization Agents Market Segmentation
Figure 2. SCAM Embolization Agents Market Segmentation, By Country
Figure 3. SCAM Embolization Agents Market Overview
Figure 4. Beads/ Particles Segment Held the Largest Share of the Product Segment in SCAM Embolization Agents Market
Figure 5. Brazil to Show Significant Growth During Forecast Period
Figure 6. South and Central America (SCAM) PEST Analysis
Figure 7. SCAM Embolization Agents Market Impact Analysis of Drivers and Restraints
Figure 8. SCAM Embolization Agents Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. SCAM Embolization Agents Market Revenue Share, by Products (2021 and 2028)
Figure 10. Coils: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 11. Beads/Particles: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12. Plugs: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 13. Detachable Balloons: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 14. Glue: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. Sponge: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 16. Liquid Embolics: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 17. Sclerosants: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18. Precipitating Agents: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 19. Others: SCAM Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 20. SCAM Embolization Agents Market, by Application 2021 & 2028 (%)
Figure 21. Oncology: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Neurology: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Urology: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Cardiology: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Peripheral Vascular Diseases: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. SCAM Embolization Agents Market Revenue Share, By End User (2021 and 2028)
Figure 28. Hospitals: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Cardiac Centers: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Ambulatory Surgical Centers: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Others: SCAM Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. South and Central America: Embolization Agents Market, By Key Country – Revenue (2021) (USD Million)
Figure 33. South and Central America: Embolization Agents Market, by Country, 2021 & 2028 (%)
Figure 34. Brazil: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 35. Argentina: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 36. Rest of South and Central America: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 37. Impact of COVID-19 Pandemic in South & Central America Market
- Abbott
- Boston Scientific Corporation
- Cook Medical LLC
- DePuy Synthes
- KANEKA CORPORATION
- Medtronic
- Merit Medical Systems Inc
- Stryker Corporation
- Terumo Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Nov 2021
Wheelchair and Mobility Aids Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Wheelchairs (Manual, Powered, Power Assisted, and Accessories), Mobility Scooters, Walking Aids, and Others), Application (Neurologically Impaired, Handicap Patients, and Other Applications), End User (Homecare, Hospitals and Clinics, Rehabilitation Centers, and Others), and Distribution Channel (Online and Offline)
Nov 2021
Cystoscopy and Ureteroscopy Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type [Cystoscope (Rigid and Flexible), and Ureteroscope (Flexible and Semi-Flexible)], Procedure (Stone Management, Bladder Cancer, Benign Prostatic Hyperplasia, and Others), Technology (Fiberoptic and Video), Usage Type (Reusable and Single Use), End User (Hospitals, Ambulatory Surgical Centers and Specialty Clinics), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, South and Central America)
Nov 2021
Cancer Drugs Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Chemotherapy, Targeted Therapy, Radiation Therapy, Hormone Therapy, and Other Therapy Types), By Indications (Blood Cancer, Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, Cervical Cancer, Liver and Intrahepatic Bile Ducts Cancer, Thyroid Cancer, and Other Indications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Stores), and Geography
Nov 2021
Walking Aids Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Canes, Crutches, Walkers, Rollators, and Others), Age Group (Adults and Pediatric), Application (Neurologically Impaired, Handicap Patients, and Others), End User (Homecare, Hospitals and Clinics, Rehabilitation Centers, and Others), and Distribution Channel (Online and Offline)
Nov 2021
Infectious Disease In vitro Diagnostics Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Application (HIV or AIDS, Tuberculosis, Hepatitis B and C, Malaria, and Others), End User (Hospitals and Clinics, Diagnostic Laboratories, Blood Bank, and Others), and Geography
Nov 2021
Donor Blood Components Market
Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care During Chemotherapy, Surgery, and Others), Age Group (Adult and Child), End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others), and Geography
Nov 2021
Aesthetic Injectable Devices Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product (Dermal Filler, Botulinum Toxin and Others), Dermal Fillers (Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polymethylmethacrylate, Fat Fillers, and Others), Device Type (Microcannulas, Pre-Filled Syringes, Mesotherapy Guns, and Others), Application (Facial Line Correction, Face Lift, Lip Treatment, Anti-Ageing and Wrinkle Treatment, Acne and Scar Treatment, Stretch Marks, and Others), Age Group (Up to 30, 31-40, 41-50, 51-60, and More Than 60), Gender (Female and Male), End User (Medical Spas, Dermatology Clinics, Hospitals, and Others), and Geography
Nov 2021
ECG Monitoring Equipment Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Resting ECG, Stress ECG, Holter Monitors, and Cardiopulmonary Stress Testing Monitors), Lead Type (12-Lead ECG, 3–6 Lead ECG, and Single Lead), Technology [Portable (Wired) ECG System and Wireless ECG System], End User (Hospital and Clinics, Ambulatory Surgical Centers, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Get Free Sample For